A high-level intro to peptide fundamentals: structure, signaling, delivery, and the regulatory picture, ahead of the deeper pharmacology dive.
This overview distills our Strive Sessions webinar with Rex Jones, PharmD, Strive Pharmacy. The written version below covers the essentials; the full session goes deeper.
Few areas in personalized medicine are moving as quickly as peptides, spanning metabolic support, endocrine physiology, tissue signaling research, and broader personalized medicine conversations. As that interest grows, a clear grasp of the fundamentals is what separates confident prescribing from guesswork.
Peptides 101: What the Webinar Covers
In the full Strive Sessions webinar, Rex Jones, PharmD, walks through four core areas:
- Peptide biology: what peptides are, their structure, and their fundamental molecular properties
- Peptide signaling: how peptides interact with cellular receptors to produce their potential biological effects
- Peptide pharmacology: the pharmacokinetic and pharmacodynamic behavior that sets peptides apart from small molecule drugs
- Clinical considerations: delivery methods, dosing constraints, and the patient-specific factors that shape peptide regimens
The sections below summarize the essentials. The session itself is where each area is unpacked in full.
Peptides vs. Proteins: Why the Distinction Matters Clinically
A peptide is a short chain of amino acids, generally about 2 to 50, that typically functions as a biological signaling molecule. Endogenous examples like insulin, glucagon, oxytocin, and vasopressin operate within broader signaling networks tied to metabolism, endocrine activity, fluid balance, and cellular coordination.
The structural contrast with proteins is more than academic. Proteins run hundreds to thousands of amino acids and fold into complex three-dimensional shapes with structural and enzymatic roles. Peptides are shorter and simpler, and they tend to act as signaling molecules at cell surface receptors. Because sequence drives folding, even small changes may alter receptor binding, signaling intensity, and selectivity. That is precisely why peptide structure and physiologic function are so tightly linked in practice.
Watch the Full Peptides Webinar
A written overview can outline the concepts, but the full Strive Sessions webinar is where the material comes to life. Rex Jones, PharmD, of Strive Pharmacy walks through peptide biology, signaling, pharmacology, and clinical considerations with the depth and real-world reasoning that shape day-to-day prescribing decisions. If peptides might become part of your practice, this is the session to watch.
How Do Peptides Work? Peptide Mechanism of Action
Most peptide medications act through cell surface receptor-mediated signaling rather than passive intracellular diffusion. The basic sequence is familiar:
- The peptide binds its receptor.
- The receptor undergoes a conformational change.
- That change initiates an intracellular signaling cascade that amplifies the original signal.
- The cell adjusts its behavior and coordinates a broader physiologic response.
The clinically important nuance is where peptide pharmacology diverges most sharply from small molecule assumptions: downstream signaling may persist after circulating peptide levels decline, and plasma half-life can be a poor proxy for biologic activity.
Go deeper: Receptor families, signaling cascades, desensitization dynamics, and the PK/PD dissociation that shapes dose interpretation are all covered in our companion piece, Why Peptides Often Play by Their Own Rules: Understanding Peptide Pharmacology.
Peptide Administration Routes: Why Delivery Method Matters
Route selection with peptides is a clinical decision, not a convenience. Because peptides are frequently susceptible to enzymatic degradation and may show limited membrane permeability, administration route can materially influence stability, bioavailability, tissue access, and regimen practicality. A quick reference:
- Subcutaneous (SubQ): The most commonly discussed systemic route. May support more stable exposure patterns while remaining practical for repeated administration.
- Intramuscular (IM): Rapid absorption and a high peak concentration, but quicker clearance, not practical for daily administration.
- Intranasal: Of particular interest where central nervous system access is being explored.
- Oral: Often limited by gastrointestinal degradation, though achievable with stable peptides or specialized formulations, and relevant when GI-local action is the goal.
- Sublingual and buccal: May bypass some first-pass metabolism and gut degradation, with absorption that varies by peptide.
Many peptides have short biological durations and may call for frequent administration. Matching route to a patient's tolerance where possible and daily routine is part of designing a regimen a patient will actually adhere to.
Assessing Peptide Response Without a Clear Lab Marker
Providers may not always have a straightforward laboratory value that fully captures how peptide-related signaling is unfolding. In many cases, assessment leans on the functional response you observe, alongside administration strategy, dosing frequency, physiologic variability, and patient-specific goals.
That reality is why peptide regimens often rely on mechanistic reasoning, evolving clinical interpretation, and real-world observation, tailored to the individual in front of you rather than a one-size-fits-all model. Providers shouldn't have to choose between standardized care and personalized solutions. Peptides are one place where individualized, prescriber-guided design comes to the foreground.
Are Compounded Peptides FDA-Approved?
Compounded peptide preparations are not FDA-approved, and they're distinct from both investigational agents and FDA-approved peptide medications. Compounded medications are specially prepared for an individual patient's needs based on a valid prescription. Compounding is a lawful, regulated, and intentional part of the care landscape, one that exists to give providers and patients more options for personalized care, working alongside commercially available medicine.
Peptide-based medications appear across many areas of clinical interest, and many peptide-based medications are FDA-approved and used across specialties, including metabolic function and weight management support, hormone signaling and endocrine function support, cell-signaling and diagnostic research in oncology, immune function support and inflammatory modulation, and support for reproductive physiology.
Continue Learning About Peptides
This primer is the orientation. From here, there are two ways to go deeper.
Watch the full Strive Sessions webinar with Rex Jones, PharmD, for the complete expert walkthrough. Seeing the signaling sequence laid out and hearing the clinical reasoning behind it lands in a way a summary cannot.
Or continue to the companion piece for the clinical pharmacology layer. It covers signaling persistence after plasma decline, why half-life interpretation is layered, receptor dynamics, and the sources of patient-to-patient variability:
→ Why Peptides Often Play by Their Own Rules: Understanding Peptide Pharmacology
Peptides are shifting medicine toward a more signaling-based, patient-specific approach. For providers navigating that shift, a firm grasp of the fundamentals is where confident, individualized prescribing begins.
Peptide FAQs for Providers
What distinguishes a peptide from a protein clinically?
Peptides are shorter (roughly 2 to 50 amino acids), structurally simpler, and typically signal at cell surface receptors. Proteins are much larger, fold into complex shapes, and serve structural and enzymatic roles. Sequence changes may shift receptor binding and selectivity.
How do most peptide medications exert their activity?
Through cell surface receptor-mediated signaling: the peptide binds its receptor, the receptor changes conformation, and an intracellular cascade amplifies the signal into a functional response.
Why does administration route matter so much with peptides?
Peptides are often susceptible to enzymatic degradation and may have limited membrane permeability, so route can materially influence absorption, bioavailability, exposure stability, and regimen practicality.
Are compounded peptides FDA-approved?
No. Compounded peptides are not FDA-approved. They are specially prepared for an individual patient based on a valid prescription from a licensed healthcare provider. Although the FDA does not review or approve compounded medications, compounding pharmacies must operate under applicable federal and state laws, pharmacy licensing requirements, and established compounding standards. Strive is licensed in every state where it dispenses medications and maintains NABP and PCAB/ACHC accreditation. We also follow established quality processes, including ingredient sourcing and applicable potency, sterility, and endotoxin testing.
How should response be assessed when there's no clean lab marker?
Assessment often relies on the observed functional response together with administration strategy, dosing frequency, physiologic variability, and patient-specific goals, rather than a single laboratory value.
Register for the Next Strive Sessions Webinar
Strive Sessions is our ongoing, provider-focused education series, built for clinicians who want to go beyond the averages and prescribe for the individual in front of them. Each session brings a Strive Pharmacy expert together with the science, the clinical reasoning, and the practical considerations that shape personalized care.
Want to join the next one live and bring your questions to the Q&A? Save your seat below.
Register for the next Strive Sessions webinar
Disclaimer:
The information provided in this blog article is for informational and educational purposes only. The information in this blog article is not intended as a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking medical attention because of something you have read in this blog article. The creators of this content disclaim any liability for decisions made based on the information presented.
Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. These statements have not been evaluated by the FDA.
